Coenzyme Q10 and Pyridoxal Phosphate Deficiency Is a Common Feature in Mucopolysaccharidosis Type III.

Autor: Yubero, Dèlia, Montero, Raquel, O'Callaghan, Mar, Pineda, Mercè, Meavilla, Silvia, Delgadillo, Veronica, Sierra, Cristina, Altimira, Laura, Navas, Plácido, Pope, Simon, Oppenheim, Marcus, Neergheen, Viruna, Ghosh, Arunabha, Mills, Phillipa, Clayton, Peter, Footitt, Emma, Cleary, Maureen, Hargreaves, Iain, Jones, Simon A., Heales, Simon

Publikováno v: JIMD Reports, Volume 25; 2016, p1-7, 7p

Coenzyme Q 10 and Pyridoxal Phosphate Deficiency Is a Common Feature in Mucopolysaccharidosis Type III.

Autor: Yubero D; Clinical Chemistry, Gastroenterology and Neurology Departments, Hospital Sant Joan de Déu, Barcelona, 08950, Spain., Montero R; Clinical Chemistry, Gastroenterology and Neurology Departments, Hospital Sant Joan de Déu, Barcelona, 08950, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., O'Callaghan M; Clinical Chemistry, Gastroenterology and Neurology Departments, Hospital Sant Joan de Déu, Barcelona, 08950, Spain., Pineda M; Clinical Chemistry, Gastroenterology and Neurology Departments, Hospital Sant Joan de Déu, Barcelona, 08950, Spain., Meavilla S; Clinical Chemistry, Gastroenterology and Neurology Departments, Hospital Sant Joan de Déu, Barcelona, 08950, Spain., Delgadillo V; Clinical Chemistry, Gastroenterology and Neurology Departments, Hospital Sant Joan de Déu, Barcelona, 08950, Spain., Sierra C; Clinical Chemistry, Gastroenterology and Neurology Departments, Hospital Sant Joan de Déu, Barcelona, 08950, Spain., Altimira L; Clinical Chemistry, Gastroenterology and Neurology Departments, Hospital Sant Joan de Déu, Barcelona, 08950, Spain., Navas P; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide-CSIC-JA, Sevilla, Spain., Pope S; Neurometabolic Unit, National Hospital, Queen Square, London, UK., Oppenheim M; Neurometabolic Unit, National Hospital, Queen Square, London, UK., Neergheen V; Neurometabolic Unit, National Hospital, Queen Square, London, UK., Ghosh A; Willink Unit, Manchester Centre for Genomic Medicine, CMFT, University of Manchester, Manchester, UK., Mills P; Genetics and Genomic Medicine, UCL Institute of Child Health, London, UK., Clayton P; Genetics and Genomic Medicine, UCL Institute of Child Health, London, UK., Footitt E; Genetics and Genomic Medicine, UCL Institute of Child Health, London, UK., Cleary M; Genetics and Genomic Medicine, UCL Institute of Child Health, London, UK., Hargreaves I; Neurometabolic Unit, National Hospital, Queen Square, London, UK., Jones SA; Willink Unit, Manchester Centre for Genomic Medicine, CMFT, University of Manchester, Manchester, UK., Heales S; Chemical Pathology, Great Ormond Street Hospital, London, UK.; Neurometabolic Unit, National Hospital, Queen Square, London, UK.; Genetics and Genomic Medicine, UCL Institute of Child Health, London, UK., Artuch R; Clinical Chemistry, Gastroenterology and Neurology Departments, Hospital Sant Joan de Déu, Barcelona, 08950, Spain. rartuch@hsjdbcn.org.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain. rartuch@hsjdbcn.org.

Publikováno v: JIMD reports [JIMD Rep] 2016; Vol. 25, pp. 1-7. Date of Electronic Publication: 2015 Jul 24.